Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: An external quality assurance exercise of the European antimicrobial resistance surveillance system (EARSS) in collaboration with the United Kingdom national external quality assurance scheme (UK NEQAS)

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 6, 2002, Pages 953-964

  Bronzwaer, S ^a   Buchholz, U ^a   Courvalin, P ^b,f   Snell, J ^c   Cornaglia, G ^d,f   de Neeling, A ^a,f   Aubry Damon, H ^d,f   Degener, J ^e   Mittermayer, H ^f   Koller, W ^f   Goossens, H ^f   van Loock, F ^f   Markova, B ^f   Urbaskova, P ^f   Sorensen T L ^f   Monnet, D ^f   Huovinen, P ^f   Lyytikainen O ^f   Witte, W ^f   Breuer, T ^f   Legakis, N ^f   Vatopoulos, G ^f   Konkoly Thege, M ^f   Kristinsson, K ^f   Briem, H ^f   Murphy, O ^f   O'Flanagan, D ^f   Raz, R ^f   Moro, M L ^f   Hemmer, R ^f   Borg, M ^f   Goettsch, W ^f   Hoiby, E ^f   Aavitsland, P ^f   Hryniewicz, V ^f   Canica M ^f   Paixao, M ^f   Gubina, M ^f   Baquero, F ^f   Campos, J ^f   Olsson Liljequist, B ^f   Cars, O ^f   Johnson, A ^f   Wale, M ^f   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b INSTITUT PASTEUR   (France)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; METICILLIN; OXACILLIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG SURVEILLANCE PROGRAM; EUROPE; HEMOLYTIC STREPTOCOCCUS; ISRAEL; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

DRUG RESISTANCE, BACTERIAL; EUROPE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; INTERNATIONAL COOPERATION; ISRAEL; MICROBIAL SENSITIVITY TESTS; QUALITY ASSURANCE, HEALTH CARE; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 12244257796     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf231     Document Type: Article

References (16)

1. EUCAST. (2000). The setting of antimicrobial breakpoints Clinical Microbiology and Infection 5, 12.
2. EARSS website. (2001). EARSS Manual. EARSS management Team. [Online.] http://www.earss.rivm.nl (21 June 2002, date last accessed).
3. Tomasz, A., Nachman, S. & Leaf, H. (1991). Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrobial Agents and Chemotherapy 35, 124-9.
4. UK-NEQAS website. (2000). Report of External Quality Assessment Exercise EARSS-NEQAS 2000. UK-NEQAS. [Online.] http://www.pcug.co.uk/~ukneqasm/ and at http://www.earss.rivm.nl (21 June 2002, date last accessed).
5. Bergan, T., Bruun, J., Digranes, A., Lingaas, E., Melby, K. & Sander, J. (1997). Susceptibility testing of bacteria and fungi. Report from the Norwegian working group on antibiotics. Scandinavian Journal of Infectious Diseases, Suppl. 1, 103.
6. Tenover, F. C., Mohammed, M. J., Stelling, J., O'Brien, T. & Williams, R. (2001). Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. Journal of Clinical Microbiology 39, 241-50.
7. The British Society for Antimicrobial Chemotherapy (BSAC) website. (1998). Standardized disc sensitivity testing method, The Newsletter of the British Society for Antimicrobial Chemotherapy, 1998. BSAC, Birmingham, UK. Update available online at: http://www.bsac.org.uk/discdiff/sensitivity2.pdf (21 June 2002, date last accessed).
8. Commissie Richtlijnen Gevoeligheidsbepalingen. (1996). Nederlands Tijdschrift voor Medische Microbiologie 4, 5.
9. Cars, O. (Ed.) (1997). Antimicrobial susceptibility testing in Sweden. Scandinavian Journal of Infectious Diseases, Suppl. 1, 105.
10. Société Frančaise de Microbiologie. (1996). Report of the Comité de I'Antibiogramme de la Société Française de Microbiologie. Clinical Microbiology and Infection 2, Suppl. 1, S1-49.
11. MENSURA. (2000). Recomendaciones del grupo MENSURA para la selección de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretación del antibiograma. Revista Española Quimoterapia 13, 73-86.
12. Deutsches Institut für Normung. (1998). Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents. MIC Breakpoints of Antibacterial Agents, Suppl. 1, pp. 58940-4. DIN, Berlin.
13. Degener, J. E. & Phillips, I. (2001). Comparison of antimicrobial susceptibility test breakpoints of national societies. Clinical Microbiology and Infection 7, 51-4.
14. Baquero, F. (1990). European standards for antibiotic susceptibility testing: towards a theoretical consensus. European Journal of Clinical Microbiology and Infectious Diseases 7, 492-5.
15. Forster, D. H., Krause, G., Gastmeier, P., Ebner, W., Rath, A., Wischnewski, N. et al. (2000). Can quality circles improve hospital-acquired infection control? Journal of Hospital Infection 45, 302-10.
16. Snell, J. S. & Brown, D. F. J. (2001). External quality assessment of antimicrobial susceptibility testing in Europe. Journal of Antimicrobial Chemotherapy 47, 801-10.